KCTD12 and colorectal cancer: Notably, reduced KCTD12 expression enhances the stemness of colorectal cancer cells—promoting self-renewal, tumorigenesis, and drug resistance—through modulation of the ERK pathway downstream of GABA signaling, leading to poor prognosis [32].